Browsing by Author Zea, Antonio

Showing results 1 to 5 of 5
TitleAuthor(s)???itemlist.dc.contributor.advisor??????itemlist.dc.contributor.editor??????itemlist.dc.contributor.titulacion???Issue Date???itemlist.dc.identifier.doi??????itemlist.dc.source??????itemlist.dc.description.sjr??????itemlist.dc.description.sjrq??????itemlist.dc.description.jcr??????itemlist.dc.description.jcrq???TypePreview
Incidence and risk of hospitalisation due to shingles and chickenpox in patients with rheumatic diseases treated with TNF antagonistsGarcía-Doval, Ignacio; Pérez-Zafrilla, Beatriz; Descalzo, Miguel Ángel; Roselló, Rosa; Hernández, Ma Victoria, et al201010.1136/ard.2009.125658Annals of the Rheumatic Diseases[ISSN 0003-4967],v. 69, p. 1751-17559,082Q1Artículo
Comprehensive description of clinical characteristics of a large systemic lupus erythematosus cohort from the spanish rheumatology society lupus registry (RELESSER) with emphasis on complete versus incomplete lupus differencesRúa-Figueroa, Íñigo; Richi, Patricia; López-Longo, Francisco Javier; Galindo, María; Calvo-Alén, Jaime, et al201510.1097/MD.0000000000000267Medicine (United States)[ISSN 0025-7974],v. 94, p. e2670,856Q12,133Q2Artículo
Relationship between damage clustering and mortality in systemic lupus erythematosus in early and late stages of the disease: Cluster analyses in a large cohort from the Spanish Society of Rheumatology Lupus RegistryPego-Reigosa, José María; Lois-Iglesias, Ana; Rúa-Figueroa, Íñigo; Galindo, María; Calvo-Alén, Jaime, et al201610.1093/rheumatology/kew049Rheumatology (United Kingdom)[ISSN 1462-0324],v. 55 (kew049), p. 1243-12501,563Q24,818Q1Artículo
Characterization of patients with lupus nephritis included in a large cohort from the Spanish society of rheumatology registry of patients with systemic lupus erythematosus (RELESSER)Galindo-Izquierdo, María; Rodriguez-Almaraz, Esther; Pego-Reigosa, Jose M.; López-Longo, Francisco J.; Calvo-Alén, Jaime, et al201610.1097/MD.0000000000002891Medicine (United States)[ISSN 0025-7974],v. 95 (e2891)0,597Q21,804Q2Artículo
Should tumour necrosis factor antagonist safety information be applied from patients with rheumatoid arthritis to psoriasis? Rates of serious adverse events in the prospective rheumatoid arthritis BIOBADASER and psoriasis BIOBADADERM cohortsGarcía-Doval, I.; Hernández, M. V.; Vanaclocha, F.; Sellas, A.; de la Cueva, P., et al201710.1111/bjd.14776British Journal of Dermatology[ISSN 0007-0963],v. 176, p. 643-6492,166Q16,129Q1Artículo